What is Zacks Research's Estimate for MTD Q2 Earnings?

Mettler-Toledo International Inc. (NYSE:MTD - Free Report) - Investment analysts at Zacks Research lowered their Q2 2025 EPS estimates for Mettler-Toledo International in a research note issued on Thursday, May 22nd. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will post earnings per share of $9.55 for the quarter, down from their prior forecast of $10.18. The consensus estimate for Mettler-Toledo International's current full-year earnings is $42.71 per share. Zacks Research also issued estimates for Mettler-Toledo International's Q4 2026 earnings at $14.08 EPS, FY2026 earnings at $45.83 EPS, Q1 2027 earnings at $10.55 EPS and FY2027 earnings at $54.17 EPS.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The firm had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. During the same period last year, the company earned $8.89 earnings per share. The business's revenue was down 4.6% on a year-over-year basis.

Several other research analysts have also recently weighed in on the stock. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a report on Tuesday, April 22nd. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their price target for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research note on Monday, April 7th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $1,302.11.

Mettler-Toledo International Stock Up 4.3%

Mettler-Toledo International stock traded up $47.70 during midday trading on Monday, hitting $1,161.84. 162,163 shares of the stock were exchanged, compared to its average volume of 150,069. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,546.93. The stock has a market capitalization of $24.15 billion, a price-to-earnings ratio of 28.67, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40. The business's 50-day moving average price is $1,096.96 and its 200-day moving average price is $1,208.03.

Hedge Funds Weigh In On Mettler-Toledo International

Several institutional investors and hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC grew its holdings in Mettler-Toledo International by 131,246.3% in the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after acquiring an additional 385,864 shares during the last quarter. Norges Bank purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $372,954,000. Proficio Capital Partners LLC purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $163,216,000. Alliancebernstein L.P. raised its holdings in Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after buying an additional 126,147 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its holdings in Mettler-Toledo International by 36.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock worth $444,327,000 after buying an additional 96,300 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.